SG/PUT/EDWARDS LIFESCIENCES/80/0.1/21.03.25 | Market Closed - Boerse Frankfurt Warrants 15:40:46 2024-05-24 EDT | ||
| 0.77 EUR | -2.53% |
|
| Current month | -23.76% | ||
| 1 month | -21.43% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24-05-24 | 0.77 | -2.53% |
| 24-05-23 | 0.79 | +9.72% |
| 24-05-22 | 0.72 | -1.37% |
| 24-05-21 | 0.73 | -3.95% |
| 24-05-20 | 0.76 | -6.17% |
Real-time Boerse Frankfurt Warrants
Last update May 24, 2024 at 03:40 pm
More quotesStatic data
| Product type | Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Société Générale
|
| WKN | SU6Q18 |
| ISIN | DE000SU6Q180 |
| Date issued | 2024-01-08 |
| Strike | 80 $ |
| Maturity | 2025-03-21 (299 Days) |
| Parity | 10 : 1 |
| Emission price | 1.67 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.7 € |
|---|---|
| Lowest since issue | 0.69 € |
| Delta | -0.12x |
| Omega | 1.949 |
| Premium | 48.64x |
| Gearing | 16.58x |
| Moneyness | 0.5739 |
| Difference Strike | -7.98 $ |
| Difference Strike % | -9.98% |
| Spread | 0.01 € |
| Spread % | 1.28% |
| Theoretical value | 0.7750 |
| Implied Volatility | 80.63 % |
| Total Loss Probability | 67.55 % |
| Intrinsic value | 0.000000 |
| Present value | 0.7750 |
| Break even | 71.59 € |
| Theta | -0.02x |
| Vega | 0.02x |
| Rho | -0.02x |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
87.98
USD
Average target price
96.16
USD
Spread / Average Target
+9.30%
- Stock Market
- Warrants
- Warrant
